Cargando…

The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease

A pharmacological and genetic blockade of the dopamine D3 receptor (D3R) has shown to be neuroprotective in models of Parkinson’s disease (PD). The anxiolytic drug buspirone, a serotonin receptor 1A agonist, also functions as a potent D3R antagonist. To test if buspirone elicited neuroprotective act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas Broome, Sarah, Castorina, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837189/ https://www.ncbi.nlm.nih.gov/pubmed/35163768 http://dx.doi.org/10.3390/ijms23031845

Ejemplares similares

Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells
por: Thomas Broome, Sarah, et al.
Publicado: (2021)

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022)

Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice
por: Thomas Broome, Sarah, et al.
Publicado: (2022)

Anxiolytic Effects of Buspirone and MTEP in the Porsolt Forced Swim Test
por: Lee, Kaziya M, et al.
Publicado: (2017)

Anxiolytic-like Effects and Quantitative EEG Profile of Palmitone Induces Responses Like Buspirone Rather Than Diazepam as Clinical Drugs
por: Onofre-Campos, Daniela, et al.
Publicado: (2023)

The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2020)

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021)

Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone
por: Leggio, Gian Marco, et al.
Publicado: (2014)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Evaluation of sesamol and buspirone in stress induced anxiety in mice
por: Kumar, Anil, et al.
Publicado: (2013)

Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors
por: Mohajjel Nayebi A, A, et al.
Publicado: (2010)

Excessive levels of nitric oxide in rat model of Parkinson’s disease induced by rotenone
por: XIONG, ZHONG-KUI, et al.
Publicado: (2015)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
por: Wang, Tian, et al.
Publicado: (2020)

Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease
por: Abhangi, Kinjal V, et al.
Publicado: (2022)

Neuroprotective effects of curcumin on the cerebellum in a rotenone‐induced Parkinson’s Disease Model
por: Fikry, Heba, et al.
Publicado: (2022)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Paroxetine-induced severe sleep bruxism successfully treated with buspirone
por: Milanlıoglu, Aysel
Publicado: (2012)

Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: Fathalla, Ahmed M., et al.
Publicado: (2016)

Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease
por: El-Shamarka, Marwa El-Sayed, et al.
Publicado: (2023)

Inhibition of Axitinib on Buspirone Metabolism in vitro and in vivo
por: Zhang, Bo-Wen, et al.
Publicado: (2022)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Evidence of Oropharyngeal Dysfunction in Feeding in the Rat Rotenone Model of Parkinson's Disease
por: Gould, François D. H., et al.
Publicado: (2018)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
por: Niederberger, Ellen, et al.
Publicado: (2022)

Can Cranberry Juice Protect against Rotenone-Induced Toxicity in Rats?
por: Kurpik, Monika, et al.
Publicado: (2021)

Commentary: Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: de Souza, Marina F., et al.
Publicado: (2017)

The Pael-R gene does not mediate the changes in rotenone-induced Parkinson's disease model cells
por: Zou, Ting, et al.
Publicado: (2014)

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
por: Chiu, Ching-Chi, et al.
Publicado: (2014)

Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson's disease model rats
por: Wang, Shu-ju, et al.
Publicado: (2018)

Overexpression of Mitochondrial Ligases Reverses Rotenone-Induced Effects in a Drosophila Model of Parkinson’s Disease
por: Doktór, Bartosz, et al.
Publicado: (2019)

The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects
por: Gerritsen, Jeroen, et al.
Publicado: (2020)

Effect of buspirone on thermal sensory and pain thresholds in human volunteers
por: Pavlaković, Goran, et al.
Publicado: (2009)

Transcriptome Analysis of a Rotenone Model of Parkinsonism Reveals Complex I-Tied and -Untied Toxicity Mechanisms Common to Neurodegenerative Diseases
por: Cabeza-Arvelaiz, Yofre, et al.
Publicado: (2012)

Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i8qro7jq82g9lncf142m8dte62